Search
My Stocks
SGX
Google
Yahoo
News
TradingView
IX BIOPHARMA LTD. (42C)
SGD 0.081
+0.00% +0.00
Portfolio
Watchlist
Divs
Anns
Trans
Notes
Articles
All
Financial
Buy Back
Insider Trading
2023-02-10
Financial Statements and Related Announcement::Half Yearly Results
2023-02-09
General Announcement::Press Release: iX Biopharma Successfully Completes Phase 1 Sublingual Dexmedetomidine Clinical Study
2022-12-02
General Announcement::Reconstitution of the Board Committees
2022-11-11
General Announcement::Minutes of Annual General Meeting Held on 14 October 2022
2022-11-07
General Announcement::Appointment of Independent Non-Executive Director and Re-Constitution of the Board
2022-11-07
Change - Announcement of Appointment::Appointment of Independent Non-Executive Director
2022-11-04
Employee Stock Option/ Share Scheme::Grant of Share Awards Pursuant to iX Performance Share Plan
2022-10-21
General Announcement::IX BIOPHARMA WINS BEST CBD SUBLINGUAL EDIBLE AWARD
2022-10-14
REPL::Annual General Meeting::Voluntary
2022-10-07
REPL::Annual General Meeting::Voluntary
2022-09-22
Annual General Meeting::Voluntary
2022-09-22
Annual Reports and Related Documents::
2022-09-22
Change - Announcement of Cessation::Retirement of Independent and Non-Executive Director - Mr Low Weng Keong
2022-08-28
General Announcement::Press Release - Launch of Sublingual Dexmedetomidine Programme
2022-07-21
Placements::PROPOSED PLACEMENT OF 13,710,000 NEW ORDINARY SHARES - ALLOTMENT AND ISSUE OF SUBSCRIPTION SHARES
2022-07-19
Placements::PROPOSED PLACEMENT OF 13,710,000 NEW ORDINARY SHARES - RECEIPT OF LISTING AND QUOTATION NOTICE
2022-07-18
General Announcement::DRUG DEVELOPMENT UPDATES FOR WAFERMINE AND WAFESIL
2022-07-15
Change - Announcement of Cessation::Cessation of Director of Corporate Affairs & General Manager - Yee Chia Hsing
2022-07-12
Placements::PROPOSED PLACEMENT OF 13,710,000 NEW ORDINARY SHARES
2022-07-07
REPL::Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notice of Cessation as Substantial Shareholder - Jaspal Singh Narulla
2022-07-06
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notice of Cessation as Substantial Shareholder - Jaspal Singh Narulla
2022-02-11
Financial Statements and Related Announcement::Half Yearly Results
2022-02-11
General Announcement::Press Release: iX Biopharma Records 1H22 Net Profit of S$3.66M
2022-02-11
Request for Trading Halt::Request for Trading Halt
2022-02-11
Request for Lifting of Trading Halt::Request for Lifting Of Trading Halt
2022-02-11
Request for Lifting of Trading Halt::Request for Lifting of Trading Halt
2022-02-11
General Announcement::Request for Lifting of Trading Halt - Sponsor's Statement
2022-02-04
General Announcement::Change of Secretaries
2022-01-28
Change - Announcement of Appointment::APPOINTMENT OF NON-EXECUTIVE INDEPENDENT DIRECTOR
2022-01-28
General Announcement::APPOINTMENT OF NON-EXECUTIVE INDEPENDENT DIRECTOR & CHANGE IN COMPOSITION OF BOARD & ITS COMMITTEES
2022-01-20
General Announcement::Phillip Securities Presentation - January 2022
2022-01-09
General Announcement::WAFERMINE LICENSING TRANSACTION - RECEIPT OF UPFRONT PAYMENT
2021-12-06
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Eddy Lee Yip Hang
2021-12-06
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Albert Ho Shing Tung
2021-11-29
Annual Reports and Related Documents::
2021-11-24
General Announcement::EXCLUSIVE LICENSE AGREEMENT FOR WAFERMINE AND OTHER SUBLINGUAL KETAMINE WAFER PRODUCTS
2021-11-24
Request for Lifting of Trading Halt::Request for Lifting of Trading Halt
2021-11-24
General Announcement::REQUEST FOR LIFTING OF TRADING HALT - SPONSOR'S STATEMENT
2021-11-23
Request for Trading Halt::Request for Trading Halt
2021-11-22
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Albert Ho Shing Tung
2021-11-22
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Eddy Lee Yip Hang
2021-11-21
Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN
2021-10-27
General Announcement::CHANGES IN THE COMPOSITION OF THE BOARD AND BOARD COMMITTEES
2021-10-26
General Announcement::Minutes of Annual General Meeting held on 15 October 2021
2021-10-25
General Announcement::iX Biopharma Expands Nutraceuticals Portfolio With Innovative Anti-Aging Sublingual NAD+ Product
2021-10-15
REPL::Annual General Meeting::Voluntary
2021-10-14
General Announcement::QUESTIONS AND ANSWERS PROVIDED AHEAD OF THE UPCOMING AGM TO BE HELD ON 15 OCTOBER 2021
2021-09-29
Change - Announcement of Cessation::Retirement of Independent Non-Executive Director - Claudia Teo Kwee Yee
2021-09-29
General Announcement::iX Biopharma Signs Wafesil Licensing Agreement with China Resources Pharmaceutical Commercial Group
2021-09-28
Annual Reports and Related Documents::
«
Previous
1
2
3
4
5
»
Next
© 2023 Dividends.sg /
More Countries